$2.02
N/A
At close: Dec 16, 4:00 PM EST
$2.04
0.020.99%
After Hours: 9:28 AM EST
Comments
Loading...
Vivos Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:VVOS | Benzinga
Vivos Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 19
EPS
$-0.490
Quarterly Revenue
$6.78M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$17.32M
Analyze the earnings history of Vivos Therapeutics using advanced sorting and filters.
Vivos Therapeutics (VVOS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-19 | $-0.49 | $-0.52 | 5.77 % |
| Q2 | 2025-08-19 | $-0.55 | $-0.38 | -44.7 % |
| Q1 | 2025-05-15 | $-0.45 | $-0.40 | -12.5 % |
| Q4 | 2025-03-31 | $-0.28 | $-0.43 | 34.9 % |
Vivos Therapeutics (VVOS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-19 | $6.78M | $4.68M | 45.0 % |
| Q2 | 2025-08-19 | $3.82M | $3.70M | 3.28 % |
| Q1 | 2025-05-15 | $3.02M | $3.67M | -17.8 % |
| Q4 | 2025-03-31 | $3.70M | $3.89M | -4.94 % |
FAQ
When is Vivos Therapeutics (NASDAQ:VVOS) reporting earnings?
Vivos Therapeutics (VVOS) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 19, 2025 for Q3.
What were the latest earnings per share (EPS) for Vivos Therapeutics (NASDAQ:VVOS)?
Vivos Therapeutics (VVOS) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 19, 2025 for Q3 and the Actual EPS was $-0.49, which beat the estimate of $-0.52.
What were Vivos Therapeutics’s (NASDAQ:VVOS) revenues?
Vivos Therapeutics (VVOS) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 19, 2025 for Q3 and the Actual Revenue was $6.8M, which beat the estimate of $4.7M.
Browse earnings estimates, EPS, and revenue on all stocks.
